Zeynep Madak Erdogan's Avatar

Zeynep Madak Erdogan

@zmadake2.bsky.social

Nuclear Receptors, Health Disparities, Metabolism, Sylvia D. Stroup Scholar of Nutrition & Cancer @FSHN_Illinois , Associate Dean @GradCollegeIL, Associate Director of CRTEC @CancerCenterIL, Editor in Chief JES @EndoSocJournals, my opinions only

1,331 Followers  |  1,942 Following  |  3 Posts  |  Joined: 08.08.2023  |  1.5393

Latest posts by zmadake2.bsky.social on Bluesky

Photo of promotional displays, with a picture from the ENDO2024 poster session

Photo of promotional displays, with a picture from the ENDO2024 poster session

Photo of the video banner over the registration booths, includes a photo from ENDO2024 of a group of faculty from the NR IMPACT group

Photo of the video banner over the registration booths, includes a photo from ENDO2024 of a group of faculty from the NR IMPACT group

If you're wondering, yes, @endocrinesociety.bsky.social will use your pictures for promo material ๐Ÿ˜‚ #ENDO2025

Pretty cool to have @nrimpact.bsky.social folks featured:
@profriggins.bsky.social
@zmadake2.bsky.social
@ayeshashafi.bsky.social
@cittellylab.bsky.social
Drs Cordoba-Chacon & Treviรฑo

12.07.2025 17:54 โ€” ๐Ÿ‘ 17    ๐Ÿ” 5    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

Looking forward to receiving some of these manuscripts. #JES

08.05.2025 01:31 โ€” ๐Ÿ‘ 3    ๐Ÿ” 1    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Journals Our top-ranked peer-reviewed journals are among the first to publish major developments and discovery milestones.

Notice to Authors with the NIEHS Journal, Environmental Health Perspectives (EHP) | We welcome submissions or transfers of manuscripts now in process at EHP: #JES (Open Access, clinical and basic), and #Endocrinology (basic). Fees can be waived. Email publications@endocrine.org: bit.ly/2yCrRBi

07.05.2025 20:36 โ€” ๐Ÿ‘ 10    ๐Ÿ” 5    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0

Thank you Sean for the shout out๐Ÿ™๐Ÿป๐Ÿ™๐Ÿป๐Ÿ™๐Ÿป

31.01.2025 00:25 โ€” ๐Ÿ‘ 2    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

Thanks Becca๐Ÿ™๐Ÿป๐Ÿ™๐Ÿป๐Ÿ™๐Ÿป

16.01.2025 01:08 โ€” ๐Ÿ‘ 2    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Preview
A path to precision metabolic treatment in breast cancer: riluzole, glutamate signaling, and invasiv... Matthew J Sikora, Julie H Ostrander; A path to precision metabolic treatment in breast cancer: riluzole, glutamate signaling, and invasive lobular carcinoma, Jo

@jostrander.bsky.social and I had the opportunity to write a commentary on @profriggins.bsky.social latest work in JES - @zmadake2.bsky.social - looking toward really cool implications for understanding and leveraging the unique metabolism of lobular breast cancer.

academic.oup.com/jes/advance-...

02.01.2024 15:24 โ€” ๐Ÿ‘ 12    ๐Ÿ” 4    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0

@zmadake2 is following 20 prominent accounts